Selected aesthetic medicine treatment in patients with autoimmune diseases - a literature review
DOI:
https://doi.org/10.12775/JEHS.2023.21.01.014Keywords
autoimmune disease, immunogenicity, inflammation, connective tissue, aesthetic medicineAbstract
Introduction Interest in cosmetic procedures has been increasing. Data on practices for correcting aesthetic deficits, including those caused by autoimmune diseases are limited. There are fears of disease reactivation and exacerbation of inflammation after surgery. Aim of the study The aim of the study was to investigate the potential influence and safety of aesthetic medicine treatment - hyaluronic acid, botulinum toxin and breast augmentation with implants in patients with autoimmune diseases. Materials and methods A search was conducted using PubMed and Google Scholar databases. Articles were searched in English using the following key words: autoimmune disease, immunogenicity, inflammation, connective tissue, aesthetic medicine. Results Hyaluronic acid is considered the best filler for cosmetic procedures, mainly due to its lack of immunogenicity. No clinical studies have identified contraindications to the administration of hyaluronic acid-based dermal fillers in patients with inflammatory diseases. Botulinum toxin is essential in alleviating involuntary functions currently associated with dystonia, spasticity, and autonomic disorders. The long-term safety of implants should be assessed concerning genetic and environmental factors and whether the autoimmune disease is in remission.Conclusion With the increasing number of aesthetic procedures using hyaluronic acid, there are more reports of potential adverse events. Most side effects are associated with hypersensitivity reactions. The use of hyaluronic acid products in patients with autoimmune diseases is controversial. However, no clinical studies have identified contraindications to the administration of hyaluronic acid-based fillers. Botulinum toxin is used for healing and pain control in patients with systemic sclerosis who have suffered phalangeal ulcers. Despite epidemiological studies conducted to assess the association between breast implants and autoimmune diseases the results remain inconclusive
References
Creadore A, Watchmaker J, Maymone MBC, Pappas L, Lam C, Vashi NA. Cosmetic treatment in patients with autoimmune connective tissue diseases: Best practices for patients with morphea/systemic sclerosis. J Am Acad Dermatol. 2020 Aug;83(2):315-341. doi: 10.1016/j.jaad.2019.12.081. Epub 2020 Apr 28. PMID: 32360721.
Bisaccia E, Lugo A, Torres O, Johnson B, Scarborough D. Persistent inflammatory reaction to hyaluronic acid gel: a case report. Cutis. 2007 May;79(5):388-9. PMID: 17569402.
Monnier G, Tatu L, Michel F. New indications for botulinum toxin in rheumatology. Joint Bone Spine. 2006 Dec;73(6):667-71. doi: 10.1016/j.jbspin.2006.03.005. Epub 2006 Aug 30. PMID: 16997603.
Ribeiro PDC, Sato EI. Autoimmune/autoinflammatory syndrome induced by adjuvants: a focus on silicone. Clin Rheumatol. 2022 Nov;41(11):3275-3283. doi: 10.1007/s10067-022-06274-0. Epub 2022 Jul 7. PMID: 35798923.
MOUNT ROYAL, N.J., Jan. 9, 2023 /PRNewswire/ - Results of annual Global Survey on Aesthetic/Cosmetic Procedures of The International Society of Aesthetic Plastic Surgery
Owczarczyk-Saczonek A, Zdanowska N, Wygonowska E, Placek W. The immunogenicity of hyaluronic fillers and its consequences. Clin Cosmet Investig Dermatol. 2021; 14: 921- 934.
Murphy EJ, Fehrenbach GW, Abidin IZ, Buckley C, Montgomery T, Pogue R, Murray P, Major I, Rezoagli E. Polysaccharides-Naturally Occurring Immune Modulators. Polymers (Basel). 2023 May 19;15(10):2373. doi: 10.3390/polym15102373. PMID: 37242947; PMCID: PMC10222865.
Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011 Jan;91(1):221-64. doi: 10.1152/physrev.00052.2009. PMID: 21248167; PMCID: PMC3051404.
Huynh A, Priefer R. Hyaluronic acid applications in ophthalmology, rheumatology, and dermatology. Carbohydr Res. 2020 Mar;489:107950. doi: 10.1016/j.carres.2020.107950. Epub 2020 Feb 18. PMID: 32070808.
Bisaccia E, Lugo A, Torres O, MD, et al. op.cit.
Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg. 2002 Jun;28(6):491-4. doi: 10.1046/j.1524-4725.2002.01251.x. PMID: 12081677.
Narins RS, Brandt F, Leyden J, et al. A randomized, double blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29: 588-595
Klein AW. Skin filling. Collagen and other injectables of the skin. Dermatol Clin. 2001 Jul;19(3):491-508, ix. doi: 10.1016/s0733-8635(05)70290-4. PMID: 11599406.
Pieretti G, Rafaniello C, Fraenza F, Donniacuo M, Cuomo R, Lanzano G, Ciccarelli F, Capuano A, Nicoletti G. Hyaluronic acid-based fillers in patients with autoimmune inflammatory diseases. J Cosmet Dermatol. 2023 May 2. doi: 10.1111/jocd.15751. Epub ahead of print. PMID: 37128806.
Cumsky HJL, Pham MM, Hoss E. Use of Botulinum Toxin and Hyaluronic Acid Filler to Treat Oral Involvement in Scleroderma. Dermatol Surg. 2022 Jun 1;48(6):698-699. doi: 10.1097/DSS.0000000000003420. Epub 2022 Mar 24. PMID: 35333209.
Sharad J. Hyaluronic Acid Filler Injection for Localized Scleroderma - Case Report and Review of Literature on Filler Injections for Localized Scleroderma. Clin Cosmet Investig Dermatol. 2022 Aug 11;15:1627-1637. doi: 10.2147/CCID.S356641. PMID: 35983128; PMCID: PMC9379108.
Philipp-Dormston WG, Hilton S, Nathan M. A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg/mL hyaluronic acid dermal filler in the lips. J
Cosmet Dermatol. 2014 Jun;13(2):125-34. doi: 10.1111/jocd.12085. PMID: 24910276; PMCID: PMC4141748.
Creadore A, Watchmaker J, Maymone MBC, Pappas L, Vashi NA, Lam C. Cosmetic treatment in patients with autoimmune connective tissue diseases: Best practices for patients with lupus erythematosus. J Am Acad Dermatol. 2020 Aug;83(2):343-363. doi: 10.1016/j.jaad.2020.03.123. Epub 2020 Apr 28. PMID: 32360722.
Pirrello R, Verro B, Grasso G, Ruscitti P, Cordova A, Giacomelli R, Ciccia F, Guggino G. Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: a prospective open-label study. Arthritis Res Ther. 2019 Dec 13;21(1):286. doi: 10.1186/s13075-019- 2062-0. PMID: 31836018; PMCID: PMC6911298.
Gualdi G, Monari P, Cammalleri D, Pelizzari L, Calzavara-Pinton P. Hyaluronic acid-based products are strictly contraindicated in scleroderma-related skin
ulcers. Wounds. 2019; 31(3): 81- 84.
Jerjen R, Nikpour M, Krieg T, Denton CP, Saracino AM. Systemic sclerosis in adults. Part II: management and therapeutics. J Am Acad Dermatol. 2022 Nov;87(5):957-978. doi: 10.1016/j.jaad.2021.10.066. Epub 2022 Feb 4. PMID: 35131401.
Monnier G, Tatu L, Michel F. op.cit.
Shenavandeh S, Sepaskhah M, Dehghani S, Nazarinia M. A 4-week comparison of capillaroscopy changes, healing effect, and cost-effectiveness of botulinum toxin-A vs prostaglandin analog infusion in refractory digital ulcers in systemic sclerosis. Clin Rheumatol. 2022 Jan;41(1):95-104. doi: 10.1007/s10067-021-05900-7. Epub 2021 Sep 1. PMID: 34471968; PMCID: PMC8409478.
Motegi SI, Uehara A, Yamada K, Sekiguchi A, Fujiwara C, Toki S, Date Y, Nakamura T, Ishikawa O. Efficacy of Botulinum Toxin B Injection for Raynaud's Phenomenon and Digital Ulcers in Patients with Systemic Sclerosis. Acta Derm Venereol. 2017 Jul 6;97(7):843-850. doi: 10.2340/00015555-2665. PMID: 28358168.
Ribeiro PDC, Sato EI. op.cit.
Moreno-Urbina SI, Gameros-Palma CP, Ramos-Estrada JG, Hiracheta-Torres A. Síndrome autoinmunitario/inflamatorio inducido por adyuvantes. Reporte de caso [Autoimmune/inflammatory syndrome induced by adjuvants. Case report]. Rev Med Inst Mex Seguro Soc. 2023 Mar 1;61(2):251-255. Spanish. PMID: 37200622.
Ribeiro PDC, Sato EI. op.cit.
Colaris MJL, de Boer M, van der Hulst RR, Cohen Tervaert JW. Two hundreds cases of ASIA syndrome following silicone implants: a comparative study of 30 years and a review of current literature. Immunol Res. 2017 Feb;65(1):120-128. doi: 10.1007/s12026-016-8821-y. PMID: 27406737; PMCID: PMC5406475.
Moreno-Urbina SI, Gameros-Palma CP, Ramos-Estrada JG, Hiracheta-Torres A. Síndrome autoinmunitario/inflamatorio inducido por adyuvantes. Reporte de caso [Autoimmune/inflammatory syndrome induced by adjuvants. Case report]. Rev Med Inst Mex Seguro Soc. 2023 Mar 1;61(2):251-255. Spanish. PMID: 37200622.
Pavlov-Dolijanovic S, Vujasinovic Stupar N. Women with silicone breast implants and autoimmune inflammatory syndrome induced by adjuvants: description of three patients and a critical review of the literature. Rheumatol Int. 2017 Aug;37(8):1405-1411. doi: 10.1007/s00296- 017-3731-4. Epub 2017 May 2. PMID: 28466365.
Silva, M.M., Modolin, M., Faintuch, J. et al. Systemic Inflammatory Reaction After Silicone Breast Implant. Aesth Plast Surg 35, 789–794 (2011). doi:10.1007/s00266-011-9688-x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Inga Łopuszyńska, Justyna Stańczyk, Dominik Adamowicz, Astrik Meliksetian, Alicja Wosińska, Dorota Pazik, Katarzyna Kosecka, Aleksandra Cieślik, Anna Jargieło, Karolina Kosieradzka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 438
Number of citations: 0
